Key facts
- It has raised $2.0M; the latest was Early Stage VC ($1.5M) in Nov 2025.
- Notable investors include Boost VC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Milieu
- ·The full record, as it builds
Funding rounds
No funding rounds for Milieu are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Milieu
Producer of personalised skincare testing kits and adaptive products intended to analyse skin microbiomes and tailor care accordingly. The company's platform uses at-home microbiome swab kits, lab-based microbial analysis, and personalised skincare formulation tools, enabling individuals and skincare providers to understand skin ecosystem dynamics, select targeted options, and adapt routines as skin conditions evolve.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Ann Arbor, MI, United States
- Founded
- 2024
- Employees
- 22
- Website
- milieuskin.com/
- Ownership
- Privately Held (backing)
Milieu doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Milieu shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Milieu in its N-PORT filings yet. We sweep new filings monthly.